Intimation of Financial Results for FY 2025-26
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare reported audited financial results for FY2025-26 with revenue from operations growing 4.7% to ₹28,767.67 lakhs. Profit after tax surged 41.7% to ₹1,487.52 lakhs from ₹1,050.07 lakhs in the prior year, driven by lower finance costs (down 25.8% to ₹2,074.57 lakhs) and improved operational efficiency. The company completed its IPO in September 2025 raising ₹12,600 lakhs, resulting in cash reserves of ₹8,101.03 lakhs as of March 31, 2026. Capital work-in-progress increased significantly to ₹8,151.77 lakhs from ₹654.80 lakhs, reflecting expansion spending on new manufacturing lines. An exceptional item of ₹262.88 lakhs was recorded for IPO-related listing expenses. Statutory auditors Price Waterhouse Chartered Accountants LLP issued an unmodified (clean) opinion on the financial results.
Strong PAT growth of 41.7% exceeds the 25% threshold and signals operational efficiency gains. The clean auditor opinion and substantial IPO proceeds provide investor confidence, while heavy capital expenditure (₹8,018.64 lakhs invested in PPE and CWIP) indicates future growth potential but temporarily pressures liquidity.